Salmon cells SHK-1 internalize infectious pancreatic necrosis virus by macropinocytosis

© 2019 John Wiley & Sons Ltd.

Bibliographische Detailangaben
Veröffentlicht in:Journal of fish diseases. - 1998. - 42(2019), 7 vom: 10. Juli, Seite 1035-1046
1. Verfasser: Levicán-Asenjo, Jorge (VerfasserIn)
Weitere Verfasser: Soto-Rifo, Ricardo, Aguayo, Francisco, Gaggero, Aldo, Leon, Oscar
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Journal of fish diseases
Schlagworte:Journal Article endocytosis infectious pancreatic necrosis virus macropinocytosis replication salmonid pathogen shk-1 cells viral entry Actins
Beschreibung
Zusammenfassung:© 2019 John Wiley & Sons Ltd.
We have previously shown that infectious pancreatic necrosis virus (IPNV) enters the embryo cell line CHSE-214 by macropinocytosis. In this study, we have extended our investigation into SHK-1 cells, a macrophage-like cell line derived from the head kidney of Atlantic salmon, the most economically important host of IPNV. We show that IPNV infection stimulated fluid uptake in SHK-1 cells above the constitutive macropinocytosis level. In addition, upon infection of SHK-1 cells, IPNV produced several changes in actin dynamics, such as protrusions and ruffles, which are important features of macropinocytosis. We also observed that the Na+/H+ pump inhibitor EIPA blocked IPNV infection. On the other hand, IPNV entry was independent of clathrin, a possibility that could not be ruled out in CHSE 214 cells. In order to determine the possible role of accessory factors on the macropinocytic process, we tested several inhibitors that affect components of transduction pathways. While pharmacological intervention of PKI3, PAK-1 and Rac1 did not affect IPNV infection, inhibition of Ras and Rho GTPases as well as Cdc42 resulted in a partial decrease in IPNV infection. Further studies will be required to determine the signalling pathway involved in the macropinocytosis-mediated entry of IPNV into its target cells
Beschreibung:Date Completed 20.08.2019
Date Revised 30.09.2020
published: Print-Electronic
Citation Status MEDLINE
ISSN:1365-2761
DOI:10.1111/jfd.13009